These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 8174316)
1. Failure of passively administered antibody to hepatitis B surface antigen to augment the immune response of a low-responder population to hepatitis B vaccination. Minuk GY; German GB; Bernstein KN; Fine A; Schroeder ML; Wong WW Clin Invest Med; 1994 Feb; 17(1):61-5. PubMed ID: 8174316 [TBL] [Abstract][Full Text] [Related]
2. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen. Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161 [TBL] [Abstract][Full Text] [Related]
3. Passively acquired antibody to hepatitis B surface antigen. Pitfall in evaluating immunity to hepatitis B viral infections. Devine P; Taswell HF; Moore SB; Gilchrist GS; Jacobson TM Arch Pathol Lab Med; 1989 May; 113(5):529-31. PubMed ID: 2712676 [TBL] [Abstract][Full Text] [Related]
4. Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates. Jafarzadeh A; Zarei S; Shokri F Vaccine; 2008 Jan; 26(2):269-76. PubMed ID: 18037544 [TBL] [Abstract][Full Text] [Related]
5. Influence of maternal antibody against hepatitis B surface antigen on active immune response to hepatitis B vaccine in infants. Hu Y; Wu Q; Xu B; Zhou Z; Wang Z; Zhou YH Vaccine; 2008 Nov; 26(48):6064-7. PubMed ID: 18812198 [TBL] [Abstract][Full Text] [Related]
6. Active hepatitis B immunization with an experimental German vaccine. I. Immunogenicity studies in healthy adults. II. The primary 19 S and 7 S responses to HBsAg in healthy adults. III. Immunogenicity studies in hemodialysis patients. Scheiermann N; Kuwert EK Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):439-55. PubMed ID: 6485639 [TBL] [Abstract][Full Text] [Related]
7. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine. Shafran SD; Mashinter LD; Lindemulder A; Taylor GD; Chiu I HIV Med; 2007 Jul; 8(5):295-9. PubMed ID: 17561875 [TBL] [Abstract][Full Text] [Related]
8. Passive and active immunization against hepatitis B virus infection: optimal scheduling in healthy young adults. Minuk GY; Bohme CE; Bowen TJ Clin Invest Med; 1989 Jun; 12(3):175-80. PubMed ID: 2743636 [TBL] [Abstract][Full Text] [Related]
9. Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or after HBs vaccination: stimulation of the in vitro antibody response by interferon gamma. Böcher WO; Herzog-Hauff S; Schlaak J; Meyer zum Büschenfeld KH; Löhr HF Hepatology; 1999 Jan; 29(1):238-44. PubMed ID: 9862872 [TBL] [Abstract][Full Text] [Related]
10. The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients. Kara IH; Yilmaz ME; Suner A; Kadiroglu AK; Isikoglu B Vaccine; 2004 Sep; 22(29-30):3963-7. PubMed ID: 15364445 [TBL] [Abstract][Full Text] [Related]
11. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study. Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185 [TBL] [Abstract][Full Text] [Related]
12. Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies. Gandhi RT; Wurcel A; Lee H; McGovern B; Shopis J; Geary M; Sivamurthy R; Sax PE; Ukomadu C J Infect Dis; 2005 May; 191(9):1435-41. PubMed ID: 15809901 [TBL] [Abstract][Full Text] [Related]
13. [Results of active preventive vaccination against hepatitis B with a German vaccine]. Henning H; Laufs R; Kätzner K; Bredehorst R Z Gastroenterol; 1983 Mar; 21(3):111-4. PubMed ID: 6868717 [TBL] [Abstract][Full Text] [Related]
14. [A five-year observation on efficacy of revaccination in children of non-response to hepatitis B vaccine]. Zhuang GH; Yan H; Wang XL; Wu Q; Wang LR; Gao HY Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Jan; 40(1):8-12. PubMed ID: 16620590 [TBL] [Abstract][Full Text] [Related]
15. Study of hepatitis B (HB) vaccine non-responsiveness among health care workers from an endemic area (Taiwan). Yen YH; Chen CH; Wang JH; Lee CM; Changchien CS; Lu SN Liver Int; 2005 Dec; 25(6):1162-8. PubMed ID: 16343067 [TBL] [Abstract][Full Text] [Related]
16. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth. Jafarzadeh A; Montazerifar SJ J Ayub Med Coll Abbottabad; 2006; 18(4):4-9. PubMed ID: 17591001 [TBL] [Abstract][Full Text] [Related]
17. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors]. Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus serologic markers and anti-hepatitis B vaccination in patients with diabetes. Halota W; Muszyńska M; Pawłowska M Med Sci Monit; 2002 Jul; 8(7):CR516-9. PubMed ID: 12118201 [TBL] [Abstract][Full Text] [Related]
19. Response to vaccination against hepatitis B in patients with Behcet's disease. Erkek E; Ayaslioglu E; Erkek AB; Kurtipek GS; Bagci Y J Gastroenterol Hepatol; 2005 Oct; 20(10):1508-11. PubMed ID: 16174066 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis B immunity in adolescents and necessity for boost vaccination: 23 years after nationwide hepatitis B virus vaccination program in Taiwan. Lu JJ; Cheng CC; Chou SM; Hor CB; Yang YC; Wang HL Vaccine; 2009 Nov; 27(47):6613-8. PubMed ID: 19698812 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]